Pathology Oncology Research

, 10:197

Increased predisposition to cancer in brothers and offspring of testicular tumor patients

  • Sarolta Gundy
  • Maria Babosa
  • Márta Baki
  • István Bodrogi
Article

DOI: 10.1007/BF03033760

Cite this article as:
Gundy, S., Babosa, M., Baki, M. et al. Pathol. Oncol. Res. (2004) 10: 197. doi:10.1007/BF03033760

Abstract

Cancer susceptibility was examined in first-degree relatives of 293 testicular tumor patients (TTPs) and 586 age-matched healthy males. Significantly increased risk was found in the families of TTPs (OR: 1.4; CI: 1.08–1.79), however, except for testicular cancer of 7 brothers (OR: 11.7; CI: 1.42–256.5), and 6 various childhood tumors (bilateral Wilms’ tumor, neuroblastoma, medulloblastoma, ALL, histiocytosis-X, testicular tumor) of 200 offspring (OR: 12.9; CI: 1.54–286.2), no association with other malignancies was observed. No differences were seen between the fertility of patients and controls when occupational or socio-economic status of the families was taken into account. However, the majority of the controls (85%) fathered the first child between 20–30 years of age, while only 61% of TTPs had the first child in the same age group. TTPs fathered more girls than boys (P=0.009), and the lower male-higher female ratio of index children was also identical, irrespective of the conception taking place before or after the father’s treatment. Occupations did not, but smoking might have influenced cancer susceptibility of the patients. Aggregation of fraternal testicular tumors, and both dramatically increased cancer risk and altered sex ratio of the offspring indicate a remarkable role of hereditary factors in tumorigenesis and later consequences of a certain portion of testicular malignancies, which must be refined by molecular studies.

Keywords

testicular cancer familial cancer risk childhood tumors 

Copyright information

© Arányi Lajos Foundation 2004

Authors and Affiliations

  • Sarolta Gundy
    • 1
  • Maria Babosa
    • 3
  • Márta Baki
    • 2
  • István Bodrogi
    • 2
  1. 1.Department of Onco-CytogeneticsNational Institute of OncologyBudapest
  2. 2.Department of ChemotherapyNational Institute of OncologyBudapest
  3. 3.Second Clinic of PaediatricsSemmelweis UniversityBudapestHungary

Personalised recommendations